Rheumatoid Arthritis — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Use a non-TNF option after immunology and infection-risk review
Recurrent serious infection and bronchiectasis require multidisciplinary review of immunoglobulins, colonisation, vaccination and prophylaxis before further immunosuppression. A non-TNF mechanism may be preferred, but one named drug cannot be selected without the full comorbidity profile.
Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/musculoskeletal-conditions